We further treated lung cancer cells with IL-6 (10 ng/ml) in the presence of CDK1i or not, and found CDK1i downregulated GP130 and blocked STAT3 phosphorylation as well (Fig. 2f). The gene discussed is IL6; the disease is lung cancer.